Companies /Healthcare

Cue Biopharma

NASDAQ: CUE Biotechnology
$30.90
▲ $2.63 (+9.30%) today
Markets closed · 12:25am ET
Today · % change

Fundamentals

Market Cap
$224.5M
Revenue (TTM)
$37.7M
EPS (TTM)
$-29.46
52-Week Range
$5 – $46
Street Target
$88.00

About Cue Biopharma

Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biological drugs for the selective modulation of the human immune system to treat a variety of cancers, chronic infectious diseases, and autoimmune disorders. The company is headquartered in Cambridge, Massachusetts.

CUE Coverage